Mar 13, 2019 - Let's see if Sanofi (SNY) stock is a good choice for value-oriented investors right now from multiple angles.
Mar 12, 2019 - The FDA approves a label expansion of Regeneron's (REGN) asthma drug, Dupixent for moderate-to-severe atopic dermatitis in adolescents.
Mar 11, 2019 - Sanofi (SNY) and partner Regeneron's (REGN) Dupixent gets FDA's priority review status for inadequately controlled severe chronic rhinosinusitis with nasal polyps.
Mar 07, 2019 -
After 13 years of unpredictable sportswriters and assorted Gasbags delivering the word and their insights on the fly every afternoon at 5 p.m., SportsNet New York is cancelling "Daily News Live" and replacing it with "The Thread" a fast-paced show covering the hottest sports news of the day.
Mar 06, 2019 - The FDA accepts Roche's (RHHBY) sNDA for Xofluza to treat influenza in people at high risk of complications.
Mar 06, 2019 - Top Stock Reports for Salesforce, Booking Holdings & VMware
Mar 06, 2019 - Pharmaceutical companies are suddenly eager to lower drug prices.
Mar 04, 2019 - Novavax (NVAX) is expected to provide updates on its lead vaccine candidate, Resvax when it reports fourth-quarter 2018 results.
Mar 04, 2019 - The CHMP gives a positive opinion for the label expansion of Regeneron (REGN) and Sanofi's Dupixent for the treatment of asthma in Europe.
Feb 27, 2019 - A Senate committee roasted top executives of the biggest drugmakers. But will anything change for ordinary Americans?